Home › Teva Announces FDA Approval Of ProAir RespiClick
 

Keywords :   


Teva Announces FDA Approval Of ProAir RespiClick

2015-04-22 08:17:13| dairynetwork News Articles

Teva Pharmaceutical Industries Ltd., recently announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate) inhalation powder, a breath-actuated, multi-dose, dry-powder, short-acting beta-agonist (SABA) inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease; and for the prevention of exercise-induced bronchospasm (EIB) in patients 12 years of age and older

Tags: approval announces fda teva

Category:Agriculture and Forestry

Latest from this category

All news
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Heifers and female cows remain hot topic at sale barn
17.05Noble Research Institute to study regenerative agriculture practices in pecan silvopasture
17.05Feeding America finds highest level of money needed for food security in 20 years
Agriculture and Forestry »
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »